Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma.
Saved in:
| Title: | Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma. |
|---|---|
| Authors: | Nakamoto-Matsubara R; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Nardi V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Horick N; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA., Fukushima T; Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Han RS; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Shome R; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Ochi K; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Panaroni C; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Fulzele K; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Rexha F; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Branagan AR; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Cirstea D; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Yee AJ; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Scadden DT; Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Raje NS; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. nraje@mgh.harvard.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2024 Dec 23; Vol. 14 (1), pp. 224. Date of Electronic Publication: 2024 Dec 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
